Sui Peng

577 total citations
24 papers, 402 citations indexed

About

Sui Peng is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Sui Peng has authored 24 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 6 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Sui Peng's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Sui Peng is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Sui Peng collaborates with scholars based in China, United States and Poland. Sui Peng's co-authors include Zhenwei Peng, Ming Kuang, Junbin Liao, Shuling Chen, Yu Guo, Tianhong Su, Qian Zhou, Han Xiao, Shi‐Ting Feng and Zunfu Ke and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Radiology.

In The Last Decade

Sui Peng

21 papers receiving 399 citations

Peers

Sui Peng
Ernest Belmonte Spain
Xiao-Dong Zhu China
Tongguo Si China
Long-Zi Liu China
Zu-Shun Chen China
Yongliang Sun China
Ruoyu Shi China
Laurence Crouzet France
Ernest Belmonte Spain
Sui Peng
Citations per year, relative to Sui Peng Sui Peng (= 1×) peers Ernest Belmonte

Countries citing papers authored by Sui Peng

Since Specialization
Citations

This map shows the geographic impact of Sui Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sui Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sui Peng more than expected).

Fields of papers citing papers by Sui Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sui Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sui Peng. The network helps show where Sui Peng may publish in the future.

Co-authorship network of co-authors of Sui Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Sui Peng. A scholar is included among the top collaborators of Sui Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sui Peng. Sui Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ning, et al.. (2025). AI‐Assisted Glucocorticoid Treatment Response Prediction of Active Ulcerative Active Patients. Journal of Gastroenterology and Hepatology. 40(7). 1754–1762.
2.
Zhang, Yuting, Jing Yang, Shuo Wang, et al.. (2025). Single‐Cell Transcriptomic Analysis Reveals an Aggressive Basal‐Like Tumor Cell Subpopulation Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma. Journal of Gastroenterology and Hepatology. 40(5). 1263–1273.
3.
Tan, Li, Lixia Xu, Shunli Shen, et al.. (2024). Neoadjuvant immune-checkpoint blockade therapy combined with TACE for resectable hepatocellular carcinoma with high recurrence risk: A phase II, single-arm clinical trial (MORNING).. Journal of Clinical Oncology. 42(16_suppl). e16267–e16267. 1 indexed citations
4.
Zheng, Linli, Minghui Gu, Xiang Li, et al.. (2024). ITGA5+ synovial fibroblasts orchestrate proinflammatory niche formation by remodelling the local immune microenvironment in rheumatoid arthritis. Annals of the Rheumatic Diseases. 84(2). 232–252. 14 indexed citations
5.
Liao, Junbin, Xin Yue, Meiyan Zhu, et al.. (2022). Methyltransferase 1 is required for nonhomologous end‐joining repair and renders hepatocellular carcinoma resistant to radiotherapy. Hepatology. 77(6). 1896–1910. 46 indexed citations
6.
Xie, Wenxuan, et al.. (2022). 710P Neoadjuvant tislelizumab for resectable recurrent hepatocellular carcinoma: A non-randomized control, phase II trial (TALENT). Annals of Oncology. 33. S867–S867. 8 indexed citations
7.
Chen, Shuling, Xuezhen Zeng, Tianhong Su, et al.. (2022). Combinatory local ablation and immunotherapies for hepatocellular carcinoma: Rationale, efficacy, and perspective. Frontiers in Immunology. 13. 1033000–1033000. 26 indexed citations
8.
Peng, Zhenpeng, Yujian Zou, Han Xiao, et al.. (2022). Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population. BMC Cancer. 22(1). 709–709. 2 indexed citations
9.
Liao, Bing, Lijuan Liu, Lihong Wei, et al.. (2021). Innovative Synoptic Reporting With Seven-Point Sampling Protocol to Improve Detection Rate of Microvascular Invasion in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 726239–726239. 4 indexed citations
10.
Chen, Lili, Shuling Chen, Qian Zhou, et al.. (2021). Microvascular Invasion Status and Its Survival Impact in Hepatocellular Carcinoma Depend on Tissue Sampling Protocol. Annals of Surgical Oncology. 28(11). 6747–6757. 17 indexed citations
11.
Xiao, Han, Jiali Li, Shuling Chen, et al.. (2021). A Pre-Operative Prognostic Score for Patients With Advanced Hepatocellular Carcinoma Who Underwent Resection. Frontiers in Oncology. 11. 569515–569515. 3 indexed citations
12.
Tang, Mimi, Qian Zhou, Mengqi Huang, et al.. (2021). Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI. European Radiology. 31(11). 8615–8627. 29 indexed citations
13.
Wei, Mengchao, Shuling Chen, Jiali Li, et al.. (2020). Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A. Annals of Surgical Oncology. 27(10). 3740–3753. 5 indexed citations
14.
Chen, Shuling, Han Xiao, Jingxian Shen, et al.. (2020). The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC. European Radiology. 30(6). 3473–3485. 17 indexed citations
15.
He, Minghui, Zihao Dai, Jun Yu, et al.. (2019). Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma. Annals of Oncology. 30(6). 990–997. 90 indexed citations
16.
17.
Chen, Shuling, Huilin Jin, Zihao Dai, et al.. (2019). Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma. Cancer Medicine. 8(4). 1530–1539. 13 indexed citations
18.
Liao, Junbin, Huilin Jin, Shaoqiang Li, et al.. (2019). Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 454–454. 47 indexed citations
19.
Chen, Shuling, Shi‐Ting Feng, Han Xiao, et al.. (2018). Pretreatment prediction of Immunoscore in hepatocellular cancer: a radiomics-based clinical nomogram based on Gd- EOB-DTPA enhanced-MRI. Cancer Biology and Medicine. 15. 2. 1 indexed citations
20.
Wang, Zongren, Han Xiao, Guangyan Wei, et al.. (2018). Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model. BMC Cancer. 18(1). 1108–1108. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ernest Belmonte Breakdown of academic impact, for papers by Xiao-Dong Zhu Breakdown of academic impact, for papers by Tongguo Si Breakdown of academic impact, for papers by Long-Zi Liu Breakdown of academic impact, for papers by Zu-Shun Chen Breakdown of academic impact, for papers by Yongliang Sun Breakdown of academic impact, for papers by Ruoyu Shi Breakdown of academic impact, for papers by Laurence Crouzet
Rankless by CCL
2026